Systematic evaluation of in vitro and in vivo adventitious virus assays for the detection of viral contamination of cell banks and biological products-Reference-Cited by-同舟云学术

Systematic evaluation of in vitro and in vivo adventitious virus assays for the detection of viral contamination of cell banks and biological products

Published:2014-05 Issue:24 Volume:32 Page:2916-2926
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Gombold James,Karakasidis Stephen,Niksa Paula,Podczasy John,Neumann Kitti,Richardson James,Sane Nandini,Johnson-Leva Renita,Randolph Valerie,Sadoff Jerald,Minor Phillip,Schmidt Alexander,Duncan Paul,Sheets Rebecca L.

Funder

National Institute of Allergy and Infectious Diseases

National Institutes of Health, Department of Health and Human Services

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference17 articles.

1. Additional standards: poliovirus vaccine, live, oral;Porterfield;Federal Register Doc. Nov. 23,1960

2. Vaccine cell substrates 2004;Sheets;Expert Rev Vaccines,2004

3. US Food and Drug Administration Guidance for Industry: Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications; 2010. http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/default.htm, accessed 12/5/2012.

4. European Pharmacopoeia Version 7. Tests for extraneous agent in viral vaccines for human use. European Directorate for the Quality of Medicines and HealthCare of the Council of Europe; 2010.

5. International Conference on Harmonisation—Quality 5D, US Food and Drug Administration; 2012. http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm065005.htm, accessed 12/5/2012.

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of infectious viruses for risk‐based virus testing of CHO unprocessed bulk using next‐generation sequencing;Biotechnology Progress;2024-07-25

2. False positive findings associated with adenoviral vector-based vaccine underscore the regulatory necessity to eliminate abnormal toxicity test;Regulatory Toxicology and Pharmacology;2024-05

3. Validation of a next generation sequencing method for adventitious virus detection: Demonstration of sensitivity in multiple cell lines;Biologicals;2024-05

4. Evaluation of next-generation sequencing performance for in vitro detection of viruses in biological products;Biologicals;2024-02

5. Efficient extraction of adventitious virus nucleic acid using commercially available methods;Biologicals;2024-02